Concepedia

Wei Yu

WY

Statistics

Publications

79

Citations

3.7K

H-Index

34

Active since

1999

Affiliations

Kansas City VA Medical Center(Current)

Jining Medical University

University of Missouri–Kansas City

Jilin University

Union Hospital

Wei Yu is an author at Kansas City VA Medical Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1999–2023

79

Publications

79

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

Naoyuki Nogami, Fabrice Barlési, Mark A. Socinski et al. · Journal of Thoracic Oncology · 2021 · 303 citations · Full text

, , +10

Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials

Julien Mazières, Achim Rittmeyer, Shirish M. Gadgeel et al. · Journal of Thoracic Oncology · 2020 · 200 citations · Full text

, , +15

Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

Georg Feldmann, Nils Habbe, S. Dhara et al. · Gut · 2008 · 190 citations · Full text

, , +17

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer

Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al. · JAMA Oncology · 2023 · 186 citations · Full text

, , +17

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study

David R. Gandara, Joachim von Pawel, Julien Mazières et al. · Journal of Thoracic Oncology · 2018 · 163 citations · Full text

, , +5

1–5 of 79